MET and familial pancreatic carcinoma: Research made by Tang et al. suggested that miR‐133a‐3p can block PI3K/AKT signaling by targeting MET, EGFR, IGF1R and FGFR1 and other cytokine receptors in pancreatic cancer to inhibit bone metastasis of pancreatic cancer.25